NABP commissioned three single-issue task forces pertaining to the following topics: one of which is best practices for veterinary compounding;

"For 2017-2018, NABP commissioned three single-issue task forces pertaining to the following topics: • best practices for veterinary compounding; • long-term care pharmacy rules; and • definition of a patient-pharmacist relationship. NABP President Jeanne D. Waggener, RPh, DPh, made the following appointments for task forces and standing committees for 2017-2018. 2017-2018 Task Forces The Task Force on Best Practices for Veterinary Compounding met on August 14-15, 2017, at NABP Headquarters in Mount Prospect, IL. The task force was established in response to Resolution No. 113-1- 17, passed at the NABP 113th Annual Meeting. The resolution states that the purpose of the task force is to develop model regulations for the compounding of animal products. The task force is charged with the following objectives: 1. Review existing state laws and regulations addressing compounding of animal (non-food-producing) products. 2. Review existing federal laws and regulations pertaining to the compounding of animal (non-foodproducing) products. 3. Determine the applicable role of state boards of pharmacy in regulating the compounding of animal (non-foodproducing) products and develop model regulations to amend the Model State Pharmacy Act and Model Rules of the National Association of Boards of Pharmacy (Model Act) accordingly. Chairperson of this task force was Mark J. Hardy, PharmD, RPh, executive director, North Dakota State Board of Pharmacy. Individuals appointed to serve as members included: • Jillian Foster, MBA, PharmD, RPh, Mississippi Board of Pharmacy • Diane Halvorson, RPhTech, CPhT, North Dakota State Board of Pharmacy • Brenda McCrady, PD, RPh, Arkansas State Board of Pharmacy • William “Bill” Mixon, MS, RPh, FIACP, FACA, North Carolina Board of Pharmacy • Patti Smeelink Keim, RPh, Michigan Board of Pharmacy • Krystal Brashears Stefanyk, North Carolina Board of Pharmacy • Jenny Downing Yoakum, RPh, Texas State Board of Pharmacy • Anita Young, EdD, RPh, Massachusetts Michael Blaire, RPh, of the Arizona State Board of Pharmacy, and Leigh BriscoeDwyer, RPh, of the New York State Board of Pharmacy served as alternates. The Executive Committee liaison was Timothy D. Fensky, RPh, DPh, FACA."

source https://nabp.pharmacy/wp-content/uploads/2016/07/Innovations-Newsletter-October-2017.pdf